B220

Item no.	HY-100272-5mg
Manufacturer	MedChem Express
CASRN	112228-65-6
Amount	5mg
Quantity options	10mM/1mL 10mg 1 mg 5mg
Category	Oncology Neuroscience Neural Lineage Markers By Cell Type Carcinoma Hematology Leukemia Inhibitors & Compound Libraries Small Molecules Progenitor Markers
Type	Inhibitors
Specific against	other
Purity	99.0
Citations	[1]Mohammed Homman, et al. Pharmaceutical formulation of B220 for topical treatment of herpes. EP 2489354 A1.<br/>[2]Harbecke O, et al. The synthetic non-toxic drug 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline inhibits neutrophil production of reactive oxygen species. J Leukoc Biol. 1999 Jun;65(6):771-7.
Smiles	CC1=C(C)C=C2N=C3C(N(CCN(C)C)C4=C3C=CC=C4)=NC2=C1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	112228-65-6
Available
Product Description	B220 is an antiviral agent which can inhibit the growth of HSV-1, HSV-2 and human cytomegalovirus (CMV).
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	318.42
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer; Infection
Solubility	10 mM in DMSO
Target	CMV; HSV
Manufacturers Target	CMV; HSV
Isoform	HSV-1; HSV-2
Manufacturers Pathway	Anti-infection
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Request delivery time